Brief: Trevena Resubmits New Drug Application For Oliceridine
10/02/2020 12:20
Feb 10 (Reuters) - Trevena Inc TRVN.O :
* TREVENA RESUBMITS NEW DRUG APPLICATION FOR OLICERIDINE
* TREVENA INC - ANTICIPATES A SIX-MONTH REVIEW PERIOD BY FDA
Source text for Eikon: ID:nGNXb4Rxdh
Further company coverage: TRVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevena
See all newsTrevena Inc reports results for the quarter ended in June - Earnings Summary
Trevena Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Trevena Q2 EPS USD -0.23
Brief: Trevena Announces $2M Non-Dilutive Financing Tranche And Reduction In Outstanding Liabilities In Connection With Existing Ex-Us Royalty Financing
U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone